本页面由Tiger Trade Technology Pte. Ltd.提供服务

武田制药

18.24
+0.06000.33%
盘后18.480.2384+1.31%19:30 EDT
成交量:223.30万
成交额:4,064.87万
市值:580.49亿
市盈率:-57.28
高:18.26
开:18.24
低:18.11
收:18.18
52周最高:18.90
52周最低:12.99
股本:31.83亿
流通股本:30.92亿
量比:0.84
换手率:0.07%
股息:0.63
股息率:3.44%
每股收益(TTM):-0.3184
每股收益(LYR):-0.3042
净资产收益率:-2.26%
总资产收益率:2.69%
市净率:1.22
市盈率(LYR):-59.95

数据加载中...

公司资料

公司名字:
武田制药
交易所:
NYSE
成立时间:
1781
员工人数:
47029
公司地址:
1-1, Nihonbashi-Honcho 2-chome,Chuo,Tokyo,Japan
邮编:
103-8668
传真:
- -
简介:
Takeda Pharmaceutical Company Limited是一家在日本注册成立的上市公司成立于1925年1月12日。该公司是一家全球研发驱动的生物制药公司,专注于胃肠道与炎症、神经科学、肿瘤学以及血浆疗法和疫苗领域的治疗药物开发。其商业努力集中在关键业务领域,研发引擎聚焦于三大核心治疗领域,利用内部研究和外部合作伙伴。公司致力于将科学转化为创新药物,并通过数字化和先进技术提高运营效率。

董事

名称
职位
Christophe Weber
Chief Executive Officer and President and Representative Director
Andrew S. Plump
Director and President, Research and Development
Bruce Broussard
External Director
Emiko Higashi
External Director
イアンクラーク
External Director
Jean Luc Butel
External Director
ジョンマラガノア
External Director
Kimberly A. Reed
External Director
Koichiro Kimura
External Director
Koji Hatsukawa
External Director
Masami Iijima
Chair of the Board and External Director
Michel Orsinger
External Director
Miki Tsusaka
External Director
Milano Furuta
Chief Financial Officer and Director
Paul Stoffels
External Director
Steven Gillis
External Director
Yoshiaki Fujimori
External Director

股东

名称
职位
Christophe Weber
Chief Executive Officer and President and Representative Director
Milano Furuta
Chief Financial Officer and Director
Akiko Amakawa
CEO Chief of Staff
Andrew S. Plump
Director and President, Research and Development
Asuka Miyabashira
President, Japan Pharma Business Unit
Awny Farajallah
Chief Medical Officer
Elaine Shannon
President, Global Supply & Quality
Gabriele Ricci
Chief Data and Technology Officer
Giles Platford
President, International Business Unit
Jennifer Smoter
Chief Communications & Governance Officer
Lauren Duprey
Chief Transformation Officer
Marcello Agosti
Interim Head, Strategy and Portfolio Development
Natalie Furney
Global General Counsel
Nicola Greenway
Chief Human Resources Officer
Ramy Riad
President, Plasma-Derived Therapies Business Unit
Rhonda Pacheco
President, U.S. Business Unit and U.S. Country
Teresa Bitetti
President, Global Oncology Business Unit